TransMedics Group Inc (TMDX) Stock Up 4.0% and Still Undervalued -- GF Score: 72/100

gurufocus.com · 2026-10-06

On October 05, 2026, TransMedics Group Inc (TMDX) shares rose 4.0% to a current price of $82.99, within a 52-week range of $60.11 to $156.00. This price movemen

TickrTrends take: TransMedics Group Inc operates in the Healthcare sector where operational efficiency and revenue growth trajectories significantly influence valuation multiples. The stock's recent 4 percent gain alongside TickrTrends' undervalued designation suggests that market pricing has not yet fully reflected the company's fundamentals relative to sector comparables. Investors focused on valuation should monitor whether TMDX's GF Score of 72 out of 100 translates into sustained price discovery, particularly if Healthcare sector momentum accelerates or if the company demonstrates improved operating margins.

Read the full story at gurufocus.com →